Skip to main content
Health Catalyst, Inc. logo

Health Catalyst, Inc. — Investor Relations & Filings

Ticker · HCAT ISIN · US42225T1079 LEI · 549300223PL6GWKVJG92 US Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 858 across all filing types
Latest filing 2024-04-29 Proxy Solicitation & In…
Country US United States of America
Listing US HCAT

About Health Catalyst, Inc.

https://www.healthcatalyst.com/

Health Catalyst, Inc. is a provider of data and analytics technology and services for healthcare organizations. The company offers a cloud-based data platform, analytics software, and professional services designed to help healthcare providers manage and analyze vast amounts of information. By integrating data from disparate sources—including clinical, financial, operational, and claims systems—Health Catalyst enables data-informed decision-making. The primary objective is to achieve measurable improvements in clinical outcomes, financial performance, and operational efficiency. The company's solutions utilize AI-powered insights and are supported by deep healthcare expertise to transform complex data into actionable intelligence for enhancing patient care and reducing costs.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement
2024-04-29 English
Regulatory Filings 2024
Regulatory Filings Classification · 95% confidence The document is a detailed response letter from Health Catalyst, Inc. to the SEC's Division of Corporation Finance regarding comments on multiple filings: a Form 8-K, a Form 10-Q for the quarter ended September 30, 2023, and a Form 10-K for the fiscal year ended December 31, 2023. The letter addresses specific SEC comments on non-GAAP financial measures, lease disclosures, and certifications related to these filings. It includes references to amendments to the 10-K and plans for future disclosures in subsequent 10-Q and 10-K filings. The document is not the filings themselves but a correspondence responding to regulatory comments, including attached exhibits illustrating intended disclosure changes. It is a regulatory correspondence letter, not a full financial report or earnings release. Given the nature of the document as a formal response to SEC comments on multiple filings and amendments, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory correspondence and compliance documents that do not constitute the filings themselves.
2024-04-23 English
10-K/A
Annual Report FY 2023
2024-04-23 English
PRIMARY DOCUMENT
Director's Dealing
2024-04-17 English
Regulatory Filings 2024
Regulatory Filings
2024-04-15 English
Regulatory Filings 2024
Regulatory Filings Classification · 60% confidence The provided document text appears to be heavily encoded or corrupted, containing no readable or meaningful content related to financial reporting, regulatory announcements, or corporate filings. There are no identifiable keywords, regulatory references, fiscal period dates, or document titles that would allow classification into any specific filing category. Given the lack of substantive content and the fallback rule for documents that do not fit any category, the appropriate classification is Regulatory Filings (RNS). The confidence is moderate due to the inability to extract meaningful information but the clear absence of any other identifiable filing type.
2024-04-10 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.